Literature DB >> 17337692

Are young infants treated with erythromycin at risk for developing hypertrophic pyloric stenosis?

Nitin Maheshwai1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17337692      PMCID： PMC2083424          DOI： 10.1136/adc.2006.110007

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  13 in total

1.  Erythromycin in ELBW infants.

Authors:  Yuhko Shiima; Hirokazu Tsukahara; Ritsuyo Kobata; Kazuyo Hayakawa; Masahiro Hiraoka; Mitsufumi Mayumi
Journal:  J Pediatr       Date:  2002-08       Impact factor: 4.406

2.  Infantile hypertrophic pyloric stenosis related to ingestion of erythromycine estolate: A report of five cases.

Authors:  A SanFilippo
Journal:  J Pediatr Surg       Date:  1976-04       Impact factor: 2.545

3.  Erythromycin is a motilin receptor agonist.

Authors:  T Peeters; G Matthijs; I Depoortere; T Cachet; J Hoogmartens; G Vantrappen
Journal:  Am J Physiol       Date:  1989-09

4.  Pyloric stenosis associated with erythromycin ingested through breastmilk.

Authors:  H Stang
Journal:  Minn Med       Date:  1986-11

5.  Maternal and infant use of erythromycin and other macrolide antibiotics as risk factors for infantile hypertrophic pyloric stenosis.

Authors:  B E Mahon; M B Rosenman; M B Kleiman
Journal:  J Pediatr       Date:  2001-09       Impact factor: 4.406

6.  Regulation of migrating motor complexes by motilin and pancreatic polypeptide in human infants.

Authors:  S R Jadcherla; G Klee; C L Berseth
Journal:  Pediatr Res       Date:  1997-09       Impact factor: 3.756

7.  Surveillance for transmission and antibiotic adverse events among neonates and adults exposed to a healthcare worker with pertussis.

Authors:  Dara S Friedman; C Robinette Curtis; Stephanie L Schauer; Susan Salvi; Henry Klapholz; Thomas Treadwell; Jerry Wortzman; Kristine M Bisgard; Susan M Lett
Journal:  Infect Control Hosp Epidemiol       Date:  2004-11       Impact factor: 3.254

Review 8.  Erythromycin as a prokinetic agent in preterm neonates: a systematic review.

Authors:  S Patole; S Rao; D Doherty
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-05-17       Impact factor: 5.747

9.  Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromcyin: a case review and cohort study.

Authors:  M A Honein; L J Paulozzi; I M Himelright; B Lee; J D Cragan; L Patterson; A Correa; S Hall; J D Erickson
Journal:  Lancet       Date:  1999 Dec 18-25       Impact factor: 79.321

10.  Very early exposure to erythromycin and infantile hypertrophic pyloric stenosis.

Authors:  William O Cooper; Marie R Griffin; Patrick Arbogast; Gerald B Hickson; Shiva Gautam; Wayne A Ray
Journal:  Arch Pediatr Adolesc Med       Date:  2002-07
View more
  4 in total

Review 1.  Macrolides for the prevention and treatment of feeding intolerance in preterm low birth weight infants: a systematic review and meta-analysis.

Authors:  Sriparna Basu; Susan Smith
Journal:  Eur J Pediatr       Date:  2020-10-12       Impact factor: 3.183

2.  Can you be too premature to develop pyloric stenosis?

Authors:  Jasper Katumba-Lunyenya; Indranil Misra; Niketa Chawda; Gokul Erumbala
Journal:  BMJ Case Rep       Date:  2012-09-24

Review 3.  Use and safety of azithromycin in neonates: a systematic review.

Authors:  Coral Smith; Oluwaseun Egunsola; Imti Choonara; Sailesh Kotecha; Evelyne Jacqz-Aigrain; Helen Sammons
Journal:  BMJ Open       Date:  2015-12-09       Impact factor: 2.692

Review 4.  Post-natal erythromycin exposure and risk of infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis.

Authors:  L Murchison; P De Coppi; S Eaton
Journal:  Pediatr Surg Int       Date:  2016-09-21       Impact factor: 1.827
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.